Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04083521 · ClinicalTrials.gov registry record · NA
Effect of Bacillus Subtilis DE111® on Daily Bowel Movements
A NA study, sponsored by Deerland Enzymes.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT04083521 is a NA study that has completed, run by Deerland Enzymes. The registered enrollment target is 50 participants.
The verdict
NCT04083521, a NA study, has completed, sponsored by Deerland Enzymes.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy of Bacillus subtilis DE111® probiotic for regulation of bowel movements.
Interventions
- DIETARY_SUPPLEMENT Bacillus subtilis DE111®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2017-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04083521
The ClinicalTrials.gov registry entry for NCT04083521 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Deerland Enzymes, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bacillus subtilis DE111® is the first listed.
NCT04083521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04083521 about?
NCT04083521 is a clinical study titled "Effect of Bacillus Subtilis DE111® on Daily Bowel Movements". The purpose of this study is to determine the efficacy of Bacillus subtilis DE111® probiotic for regulation of bowel movements.
What is the current status of trial NCT04083521?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-09-01. Estimated completion is 2017-08-31.
What interventions are being tested in trial NCT04083521?
The interventions under investigation include: Bacillus subtilis DE111® (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04083521?
This trial is sponsored by Deerland Enzymes, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.